FGF21 and metabolic dysfunction-associated steatohepatitis: A study using the same FGF21 analogue molecule as ours (LY2405319) showed improvements in nonalcoholic steatohepatitis in ob/ob mice by enhancing hepatic mitochondrial function [21].